| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676b80da7ac92b84e447a83fb1630ae1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2004-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c465bdfc143a3a630070fda61d844727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4124548a25beaedb4d8e3108617db85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_515e098347f757b1522fe7cba50337d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac90c2ffc1a31317427f1e31f4828570 |
| publicationDate |
2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7700543-B2 |
| titleOfInvention |
Use NF-κB inhibition in combination therapy for cancer |
| abstract |
The use of NF-κB inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. When chemotherapeutic compounds and radiation activate NF-κB within cells, the cells are more resistant to the cytotoxic effects of these treatments. Inhibition of NF-κB activation is disclosed to provide a method to improve the efficacy of these cancer therapies. |
| priorityDate |
1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |